A LONGITUDINAL STUDY OF ABNORMALITIES ON MRI AND DISABILITY FROM MULTIPLE SCLEROSIS

A BSTRACT Background In patients with isolated syndromes that are clinically suggestive of multiple sclerosis, such as optic neuritis or brain-stem or spinal cord syndromes, the presence of lesions as determined by T 2 -weighted magnetic resonance imaging (MRI) of the brain increases the likelihood that multiple sclerosis will develop. We sought to determine the relation between early lesion volume, changes in volume, and long-term disability. Methods Seventy-one patients in a serial MRI study of patients with isolated syndromes were reassessed after a mean of 14.1 years. Disability was measured with the use of Kurtzke’s Expanded Disability Status Scale (EDSS; possible range, 0 to 10, with a higher score indicating a greater degree of disability). Results Clinically definite multiple sclerosis developed in 44 of the 50 patients (88 percent) with abnormal results on MRI at presentation and in 4 of 21 patients (19 percent) with normal results on MRI. The median EDSS score at follow-up for those with multiple sclerosis was 3.25 (range, 0 to 10); 31 percent had an EDSS score of 6 or more (including three patients whose deaths were due to multiple sclerosis). The EDSS score at 14 years correlated moderately with lesion volume on MRI at 5 years (r=0.60) and with the increase in lesion volume over the first 5 years (r=0.61). Conclusions In patients who first present with isolated syndromes suggestive of multiple sclerosis, the increases in the volume of the lesions seen on magnetic resonance imaging of the brain in the first five years correlate with the degree of long-term disability from multiple sclerosis. This relation is only moderate, so the volume of the lesions alone may not be an adequate basis for decisions about the use of disease-modifying treatment. (N Engl J Med 2002; 346:158-64.)

[1]  Robert Tibshirani,et al.  An Introduction to the Bootstrap , 1994 .

[2]  S. Holtås,et al.  A long‐term prospective study of optic neuritis: Evaluation of risk factors , 1990, Annals of neurology.

[3]  B E Kendall,et al.  Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. , 1988, Brain : a journal of neurology.

[4]  D. Miller,et al.  The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. A 5-year follow-up study. , 1993, Brain : a journal of neurology.

[5]  B Bass,et al.  The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. , 1989, Brain : a journal of neurology.

[6]  G. Comi,et al.  Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. , 1997, Brain : a journal of neurology.

[7]  J. Rizzo,et al.  Risk of developing multiple sclerosis after uncomplicated optic neuritis , 1988, Neurology.

[8]  B. Weinshenker,et al.  Multiple sclerosis. , 2000, The New England journal of medicine.

[9]  A. Thompson,et al.  Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. , 1996, Brain : a journal of neurology.

[10]  A J Thompson,et al.  Quantitative MRI in patients with clinically isolated syndromes suggestive of demyelination. , 1999, Neurology.

[11]  I. Moseley,et al.  The early risk of multiple sclerosis following isolated acute syndromes of the brainstem and spinal cord , 1989, Annals of neurology.

[12]  P. Sandercock,et al.  Magnetic resonance imaging in isolated noncompressive spinal cord syndromes , 1987, Annals of neurology.

[13]  G. Barker,et al.  The effect of section thickness on MR lesion detection and quantification in multiple sclerosis. , 1998, AJNR. American journal of neuroradiology.

[14]  A. Thompson,et al.  The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. , 1998, Brain : a journal of neurology.

[15]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[16]  D. MacManus,et al.  Magnetic resonance imaging in clinically isolated lesions of the brain stem. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[17]  S. Miller,et al.  Temporal Development of Autoreactive Th1 Responses and Endogenous Presentation of Self Myelin Epitopes by Central Nervous System-Resident APCs in Theiler’s Virus-Infected Mice1 , 2000, The Journal of Immunology.

[18]  Jonathan D. Trobe,et al.  The 5-year risk of MS after optic neuritis , 1998, Neurology.

[19]  B Bass,et al.  The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. , 1989, Brain : a journal of neurology.

[20]  O. Andersen,et al.  Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. , 1993, Brain : a journal of neurology.

[21]  F. Barkhof,et al.  Interscanner variation in brain MRI lesion load measurements in MS: Implications for clinical trials , 1997, Neurology.

[22]  Hristian,et al.  RELAPSES AND PROGRESSION OF DISABILITY IN MULTIPLE SCLEROSIS , 2000 .

[23]  Douglas G. Altman,et al.  Practical statistics for medical research , 1990 .

[24]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[25]  J. Taubenberger,et al.  Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis , 1993, Annals of neurology.

[26]  D. Paty,et al.  Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis , 1993, Neurology.

[27]  Marco Rovaris,et al.  Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study , 2001, The Lancet.

[28]  J. H. Steiger Tests for comparing elements of a correlation matrix. , 1980 .

[29]  R. Kakigi,et al.  Disseminated lesions at presentation in patients with optic neuritis. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[30]  D. Paty,et al.  CORRELATION BETWEEN NMR SCAN AND BRAIN SLICE DATA IN MULTIPLE SCLEROSIS , 1984, The Lancet.

[31]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[32]  V. Perry,et al.  Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.

[33]  B E Kendall,et al.  The early risk of multiple sclerosis after optic neuritis. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[34]  W. Mcdonald,et al.  A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[35]  P M Matthews,et al.  Imaging axonal damage of normal-appearing white matter in multiple sclerosis. , 1998, Brain : a journal of neurology.

[36]  H. Lassmann,et al.  Histopathology and the blood–cerebrospinal fluid barrier in multiple sclerosis , 1994, Annals of neurology.

[37]  J H Simon,et al.  Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. , 2000, The New England journal of medicine.

[38]  Lublin Fd,et al.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. , 1996 .

[39]  G. Aimard,et al.  Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. , 1980, Brain : a journal of neurology.

[40]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[41]  V. Torri,et al.  Long-term follow-up of isolated optic neuritis: the risk of developing multiple sclerosis, its outcome, and the prognostic role of paraclinical tests , 1999, Journal of Neurology.

[42]  G. Beebe,et al.  Studies on the natural history of multiple sclerosis--8. Early prognostic features of the later course of the illness. , 1977, Journal of chronic diseases.